Report of the international meeting on chromosome 12 genes in cancer

Cytogenetics and Cell Genetics

Volumn 73, Issue 1-2, 1996, Pages 25-32

  Van De Ven, W ^a   Hagemeijer, A ^a   Kucherlapati, R ^a   Marynen, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN;

CANCER; CHROMOSOME 12; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 12; CONFERENCE PAPER; GENE AMPLIFICATION; GENE MUTATION; GENE STRUCTURE; HUMAN; ONCOGENE; PRIORITY JOURNAL; SOLID TUMOR; STRUCTURAL CHROMOSOME ABERRATION;

ACTIVATING TRANSCRIPTION FACTOR 1; ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; DNA-BINDING PROTEINS; DWARFISM; GENE AMPLIFICATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HIGH MOBILITY GROUP PROTEINS; HUMANS; MICE; MICE, MUTANT STRAINS; NEOPLASMS; ONCOGENE PROTEINS, FUSION; ONCOGENES; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; RIBONUCLEOPROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0029979902     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65 (1995).
2. Brown AD, Lopez-Terrada D, Denny C, Lee KAW: Promoters containing ATF-binding sites are deregulated in cells that express the EWS/ATF1 oncogene. Oncogene 10:1749 (1995).
3. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, Grosveld G: Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511-1519 (1995).
4. Fejzo MS, Yoon S-J, Montgomery KT, Rein MS, Weremowicz S, Krauter KS, Dorman TE, Fletcher JA, Mao J, Moir DT, Kucherlapati RS, Morton CC: Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: Physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 26:265-271 (1995).
5. Florenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O: MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene. J natl Cancer Inst 86:1297-1302 (1994).
6. Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O: Mapping of amplification units in the q13-q14 region of chromosome 12 in human sarcomas: Some amplicons do not include MDM2. Cell Growth Differ 4:1065-1070 (1993).
7. Gallego MI, Lazo PA: Deletion in human chromosome region 12q13-q15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J biol Chem 270:24321-24326 (1995).
8. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor B to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77-307-316 (1994).
9. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc natl Acad Sci, USA 92:4917-4921 (1995).
10. Janssen JWG, Ridge SA, Papadopoulos P, Cotter F, Ludwig WD, Fonatsch C, Rieder H, Ostertag W, Bartram CR, Wiedemann LM: The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. Br J Haemat 90:222-224 (1995).
11. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34-38 (1995).
12. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA: The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85;3662-3670 (1995).
13. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, Le Beau MM, Roberts JM, Vogelstein B, Rowley JD, Bohlander SK: TEL and CDKN1B define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 86:1525-1533 (1995).
14. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van Den Berghe H, Van de Ven WJM: Recurrent rearrangements in the high mobility group protein gene, HMGIC, in benign mesenchymal tumours. Nature Genet 10:436-444 (1995).
15. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Sallan SE, Gilliland DG, Golub TR: Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86;38-44 (1995).
16. Van de Ven WJ, Schoenmakers EF, Wanschura S, Kazmierczak B, Kools PF, Geurts JM, Bartnitzke S, Van Den Berghe H, Bullerdiek J: Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chrom Cancer 12:296-303 (1995).
17. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, Van den Berghe H: TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 85:2848-2852 (1995).
18. Wlodarska I, Marynen P, La Starza R, Mecucci C, Van den Berghe H: The ETV6, CDKN1B and D12S178 loci are involved in a commonly deleted segment in various hematological 12p malignancies. Cancer Genet Cytogenet (in press).
19. Zhou XJ, Benson KF, Ashar HR, Chada K: Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771-774 (1995).
20. Zinszner H, Albalat R, Ron D: A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 8:2513-2526 (1994).